Biocryst Pharmaceuticals Stock Price History

BCRX Stock  USD 7.63  0.01  0.13%   
If you're considering investing in BioCryst Stock, it is important to understand the factors that can impact its price. As of today, the current price of BioCryst Pharmaceuticals stands at 7.63, as last reported on the 21st of March, with the highest price reaching 7.69 and the lowest price hitting 7.44 during the day. At this stage we consider BioCryst Stock to be slightly risky. BioCryst Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0109, which signifies that the company had a 0.0109 % return per unit of risk over the last 3 months. We have found thirty technical indicators for BioCryst Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm BioCryst Pharmaceuticals' Downside Deviation of 3.31, risk adjusted performance of 0.0167, and Mean Deviation of 2.19 to double-check if the risk estimate we provide is consistent with the expected return of 0.0331%.
  
BioCryst Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0109

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBCRX

Estimated Market Risk

 3.04
  actual daily
27
73% of assets are more volatile

Expected Return

 0.03
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average BioCryst Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioCryst Pharmaceuticals by adding BioCryst Pharmaceuticals to a well-diversified portfolio.

BioCryst Pharmaceuticals Stock Price History Chart

There are several ways to analyze BioCryst Stock price data. The simplest method is using a basic BioCryst candlestick price chart, which shows BioCryst Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 19, 20259.39
Lowest PriceJanuary 16, 20257.06

BioCryst Pharmaceuticals March 21, 2025 Stock Price Synopsis

Various analyses of BioCryst Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BioCryst Stock. It can be used to describe the percentage change in the price of BioCryst Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BioCryst Stock.
BioCryst Pharmaceuticals Price Action Indicator 0.06 
BioCryst Pharmaceuticals Price Daily Balance Of Power(0.04)
BioCryst Pharmaceuticals Price Rate Of Daily Change 1.00 

BioCryst Pharmaceuticals March 21, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in BioCryst Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use BioCryst Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in BioCryst Stock and then apply it to test your longer-term investment strategies against BioCryst.

BioCryst Stock Price History Data

OpenHighLowCloseVolume
03/21/2025
 7.65  7.69  7.44  7.63 
03/19/2025 7.65  7.69  7.44  7.63  2,707,720 
03/18/2025 7.70  7.74  7.53  7.64  3,258,445 
03/17/2025 7.70  7.82  7.52  7.74  2,759,509 
03/14/2025 7.59  7.74  7.57  7.70  2,718,792 
03/13/2025 7.68  7.74  7.50  7.54  2,602,095 
03/12/2025 7.65  7.95  7.59  7.71  3,696,647 
03/11/2025 7.38  7.67  7.20  7.54  4,836,860 
03/10/2025 7.55  7.63  7.25  7.38  4,362,281 
03/07/2025 7.86  7.97  7.59  7.69  4,111,560 
03/06/2025 7.93  8.04  7.74  7.86  4,536,896 
03/05/2025 8.30  8.36  7.91  8.05  4,695,535 
03/04/2025 8.14  8.39  7.67  8.31  6,622,729 
03/03/2025 8.58  8.80  8.45  8.54  4,851,882 
02/28/2025 8.46  8.66  8.41  8.61  4,230,228 
02/27/2025 8.36  8.67  8.28  8.47  4,430,582 
02/26/2025 8.32  8.57  8.15  8.36  3,416,407 
02/25/2025 8.44  8.44  7.94  8.28  3,672,512 
02/24/2025 8.87  8.96  7.95  8.29  6,078,362 
02/21/2025 9.50  9.50  9.15  9.21  5,555,579 
02/20/2025 9.39  9.50  9.29  9.39  3,415,368 
02/19/2025 9.34  9.48  9.31  9.39  4,826,716 
02/18/2025 9.10  9.45  9.09  9.36  5,333,059 
02/14/2025 8.83  9.11  8.72  9.05  5,148,611 
02/13/2025 8.87  8.90  8.63  8.82  3,654,225 
02/12/2025 8.91  9.00  8.72  8.78  2,516,997 
02/11/2025 8.57  9.00  8.54  8.99  3,116,235 
02/10/2025 8.69  8.80  8.53  8.63  1,813,616 
02/07/2025 8.74  8.87  8.59  8.72  2,340,286 
02/06/2025 8.64  8.87  8.49  8.73  3,177,587 
02/05/2025 8.16  9.00  8.15  8.61  3,721,595 
02/04/2025 7.59  8.13  7.57  8.09  2,370,866 
02/03/2025 7.72  7.73  7.54  7.62  2,184,768 
01/31/2025 7.86  8.04  7.82  7.90  1,861,865 
01/30/2025 8.08  8.14  7.80  7.87  2,221,776 
01/29/2025 7.92  8.10  7.85  8.02  1,850,230 
01/28/2025 8.01  8.07  7.90  7.93  1,747,828 
01/27/2025 7.60  8.09  7.53  8.01  3,109,428 
01/24/2025 7.64  7.85  7.55  7.64  2,197,248 
01/23/2025 7.58  7.75  7.45  7.73  2,861,091 
01/22/2025 7.59  7.67  7.46  7.62  1,829,473 
01/21/2025 7.50  7.79  7.41  7.61  3,125,231 
01/17/2025 7.04  7.49  6.96  7.45  3,964,020 
01/16/2025 7.21  7.28  6.98  7.06  2,519,104 
01/15/2025 7.45  7.47  7.16  7.23  2,365,796 
01/14/2025 7.97  8.02  7.22  7.23  2,529,179 
01/13/2025 7.77  8.00  7.54  7.93  2,690,683 
01/10/2025 8.49  8.49  7.53  7.67  4,743,967 
01/08/2025 8.11  8.29  7.99  8.05  2,145,456 
01/07/2025 7.83  8.23  7.80  8.14  1,747,511 
01/06/2025 7.64  8.07  7.64  7.83  1,629,746 
01/03/2025 7.87  8.02  7.69  7.70  1,267,149 
01/02/2025 7.59  8.10  7.48  7.83  3,106,778 
12/31/2024 7.60  7.70  7.46  7.52  1,513,767 
12/30/2024 7.65  7.71  7.48  7.53  1,448,179 
12/27/2024 7.65  7.79  7.59  7.71  998,329 
12/26/2024 7.65  7.83  7.62  7.72  1,240,701 
12/24/2024 7.73  7.84  7.60  7.67  753,880 
12/23/2024 7.57  7.82  7.38  7.78  1,523,751 
12/20/2024 7.25  7.60  7.25  7.57  5,070,885 
12/19/2024 7.34  7.48  7.22  7.39  2,017,592 

About BioCryst Pharmaceuticals Stock history

BioCryst Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioCryst is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioCryst Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioCryst Pharmaceuticals stock prices may prove useful in developing a viable investing in BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina. Biocryst Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 358 people.

BioCryst Pharmaceuticals Stock Technical Analysis

BioCryst Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of BioCryst Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BioCryst Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

BioCryst Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for BioCryst Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of BioCryst Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioCryst to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for BioCryst Stock Analysis

When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.